Empresa Protagenic Therapeutics, Inc. Other OTC
Acciones
PTIX
US74365N1037
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 01/02/16 |
Andrew Slee
COO | Chief Operating Officer | 74 | 01/02/16 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12/02/16 |
Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 03/02/94 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12/02/16 |
Brian Corvese
BRD | Director/Board Member | 67 | 28/07/17 |
Khalil Barrage
BRD | Director/Board Member | 59 | 01/07/07 |
Timothy Wright
BRD | Director/Board Member | 66 | 23/11/22 |
Jennifer Buell
BRD | Director/Board Member | 50 | 18/07/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 4 435 132 | 3 466 915 ( 78,17 %) | 0 | 78,17 % |
Información de la empresa
Protagenic Therapeutics, Inc.
149 Fifth Avenue Suite 500
10010, New York
+212 994 8200
http://www.protagenic.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+43,36 % | 54,63 mil M | |
-5,31 % | 39,92 mil M | |
+14,75 % | 26,86 mil M | |
-12,56 % | 26,22 mil M | |
-22,45 % | 18,78 mil M | |
+25,12 % | 12,21 mil M | |
+0,04 % | 12,16 mil M | |
+26,04 % | 11,94 mil M | |
-11,83 % | 10,74 mil M |